Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-10-30

Clinical Trial Update: Stress Hydrocortisone In Pediatric Septic Shock [Phase 3]

View source ↗

Summary

An ongoing Phase 3 clinical trial is evaluating stress-dose hydrocortisone in pediatric septic shock; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stress hydrocortisone (hydrocortisone)

Snippet

Sponsor: Jerry Zimmerman | Conditions: Septic Shock | Phase 3 | Status: RECRUITING